Dorman Products (DORM) Cash & Equivalents (2010 - 2026)

Dorman Products (DORM) has reported Cash & Equivalents for 17 consecutive years, with $43.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Equivalents fell 28.96% year-over-year to $43.1 million; the TTM figure through Mar 2026 stood at $43.1 million (down 28.96% YoY), while the FY2025 annual figure was $49.4 million, down 13.48% from the prior year.
• Cash & Equivalents came in at $43.1 million for Q1 2026 at Dorman Products, down from $49.4 million in the prior quarter.
• The five-year high for Cash & Equivalents was $60.6 million in Q1 2025, with the low at $32.0 million in Q3 2023.
• Average Cash & Equivalents over 5 years is $45.5 million, with a median of $46.0 million recorded in 2022.
• Across the five-year window, Cash & Equivalents tumbled 67.93% in 2022 and surged 76.03% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $46.0 million in 2022, then fell by 20.03% to $36.8 million in 2023, then surged by 55.2% to $57.1 million in 2024, then retreated by 13.48% to $49.4 million in 2025, then decreased by 12.91% to $43.1 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $43.1 million, $49.4 million, and $55.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.